Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,854 GBX | +2.26% | +4.51% | +3.63% |
Apr. 25 | Hikma Pharmaceuticals backs outlook after making strong start to 2024 | AN |
Apr. 25 | Transcript : Hikma Pharmaceuticals PLC - Shareholder/Analyst Call |
Evolution of the average Target Price on Hikma Pharmaceuticals PLC
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Hikma Pharmaceuticals PLC
RBC Capital Markets | |
alphavalue | Abhishek Raval |
JPMorgan | |
Jefferies & Co. | |
Barclays | |
Berenberg Bank | |
Morgan Stanley | |
Goldman Sachs | |
Citigroup |
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIK Stock
- Consensus Hikma Pharmaceuticals PLC